These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Shimbori C; Shiota N; Okunishi H Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736 [TBL] [Abstract][Full Text] [Related]
25. Production and function of murine macrophage inflammatory protein-1 alpha in bleomycin-induced lung injury. Smith RE; Strieter RM; Phan SH; Lukacs NW; Huffnagle GB; Wilke CA; Burdick MD; Lincoln P; Evanoff H; Kunkel SL J Immunol; 1994 Nov; 153(10):4704-12. PubMed ID: 7525712 [TBL] [Abstract][Full Text] [Related]
26. A role for dendritic cells in bleomycin-induced pulmonary fibrosis in mice? Bantsimba-Malanda C; Marchal-Sommé J; Goven D; Freynet O; Michel L; Crestani B; Soler P Am J Respir Crit Care Med; 2010 Aug; 182(3):385-95. PubMed ID: 20395561 [TBL] [Abstract][Full Text] [Related]
27. Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice. Russo RC; Garcia CC; Barcelos LS; Rachid MA; Guabiraba R; Roffê E; Souza AL; Sousa LP; Mirolo M; Doni A; Cassali GD; Pinho V; Locati M; Teixeira MM J Leukoc Biol; 2011 Feb; 89(2):269-82. PubMed ID: 21048214 [TBL] [Abstract][Full Text] [Related]
28. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin. Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102 [TBL] [Abstract][Full Text] [Related]
29. Peroxiredoxin I protects gastric mucosa from oxidative injury induced by H. pylori infection. Sato D; Yanaka A; Shibahara T; Matsui H; Nakahara A; Yanagawa T; Warabi E; Ishii T; Hyodo I J Gastroenterol Hepatol; 2008 Apr; 23(4):652-9. PubMed ID: 18005015 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin. Cabrera S; Gaxiola M; Arreola JL; Ramírez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637 [TBL] [Abstract][Full Text] [Related]
31. CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model. Besnard AG; Struyf S; Guabiraba R; Fauconnier L; Rouxel N; Proost P; Uyttenhove C; Van Snick J; Couillin I; Ryffel B J Leukoc Biol; 2013 Dec; 94(6):1317-23. PubMed ID: 23975892 [TBL] [Abstract][Full Text] [Related]
33. Exacerbation of bleomycin-induced injury and fibrosis by pneumonectomy in the residual lung of mice. Kakizaki T; Kohno M; Watanabe M; Tajima A; Izumi Y; Miyasho T; Tasaka S; Fukunaga K; Maruyama I; Ishizaka A; Kobayashi K J Surg Res; 2009 Jun; 154(2):336-44. PubMed ID: 19118846 [TBL] [Abstract][Full Text] [Related]
34. The role of high mobility group box1 in pulmonary fibrosis. Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281 [TBL] [Abstract][Full Text] [Related]